Bayer AG (LTS:0P6S) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0P6S Bayer AG LTS:0P6S
50 GF Score
Price €49.02
GF Value €27.27
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Bayer AG Short-term investments?

Short-term investments only applies to insurance companies.

LTS:0P6S
50GF Score
Bayer AG LTS:0P6S
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bayer AG (LTS:0P6S) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of €49.02 is trading 79.8% above its estimated GF Value™ of €27.27. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for LTS:0P6S:

  • Short-term investments:
  • GF Value™: €27.27 vs. price of €49.02 (79.8% above fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the LTS:0P6S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer AG is a German life sciences company organized into three divisions: Crop Science, Pharmaceuticals, and Consumer Health. Crop Science, the largest segment, sells seeds, crop protection products such as herbicides, fungicides, and insecticides, and digital farming tools, serving farmers and agricultural distributors worldwide; its portfolio was greatly expanded by the 2018 acquisition of Monsanto. Pharmaceuticals develops and markets prescription medicines in areas including cardiology, oncology, women's health, ophthalmology, and radiology. Consumer Health sells over-the-counter products in categories such as pain relief, allergy, cold and flu, dermatology, and nutrition, including brands like Aspirin, Aleve, Bepanthen, and Claritin. The company operates globally, with significant revenue in Europe, North America, and Asia, and generates sales through direct distribution and third-party wholesalers, supplemented by licensing and collaboration agreements with other pharmaceutical and biotechnology firms.
50GF Score

Get the complete analysis for LTS:0P6S

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.02
Price
€27.27
GF Value